MetaCap

AstraZeneca Insider Trades

NYSE: AZNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

159.20+0.42 (+0.26%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $3.25K
Sales
1 · $2.21M
Shares bought / sold
20.23 / 11.89K
Net activity
Net selling $2.2 million

AstraZeneca insider activity

Over the last 12 months, AstraZeneca insiders reported 9 transactions on SEC Form 4: 1 open-market purchase and 1 sale. Insiders bought $3,249 and sold $2.2 million worth of stock, for net insider selling of $2.2 million. The largest seller was Sharma Mani, with $2.2 million in reported sales.

The most recent filing shows Sharma Mani (See remarks) reporting a transaction in 2 shares at $159.80 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AZN's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AZN insider transactions

AstraZeneca insider transactions
DateInsiderTypeSharesValueFiling
Oct 6, 2026Sharma ManiSee remarksAward2$319.60Form 4
Sep 8, 2026Sharma ManiSee RemarksAward1$162.60Form 4
Aug 8, 2026Sharma ManiSee RemarksBuy20$3.25KForm 4
Aug 6, 2026Sharma ManiSVP, Group ControllerAward2$326.68Form 4
Jul 6, 2026Sharma ManiSee RemarksAward2$380.86Form 4
Jun 8, 2026Sharma ManiSee RemarksAward1$179.75Form 4
May 20, 2026Sharma ManiSee RemarksSale11,893$2.21MForm 4
May 6, 2026Sharma ManiSee RemarksAward1$186.28Form 4
Apr 7, 2026Sharma ManiSee RemarksAward1$196.03Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related